STE

STERIS plc · NYSE · Healthcare · USD · 10-K for 2026, filed 2026-05-29

Figures on this page computed 2026-11-08 12:24 UTC

Last close

247.91USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2026, filed 2026-05-29

31.7xP/E
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2026
Accession
0001628280-26-039136
Reported in
USD
- computed
- 10-K for 2026, filed 2026-05-29
The filing itself
9.3%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2026
Accession
0001628280-26-039136
Reported in
USD
- 10-K for 2026, filed 2026-05-29
- 10-K for 2026, filed 2026-05-29
- 10-K for 2026, filed 2026-05-29
- 10-Q for 2026, filed 2026-08-07
- 10-K for 2026, filed 2026-05-29
- 10-Q for 2026, filed 2026-08-07
The filing itself
13.2%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2026
Accession
0001628280-26-039136
Reported in
USD
- 10-K for 2026, filed 2026-05-29
- 10-K for 2026, filed 2026-05-29
The filing itself
16.4%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2026
Accession
0001628280-26-039136
Reported in
USD
- 10-K for 2026, filed 2026-05-29
- 10-K for 2026, filed 2026-05-29
The filing itself
0.29Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2026
Accession
0001628280-26-039136
Reported in
USD
- 10-K for 2026, filed 2026-05-29
- 10-Q for 2026, filed 2026-08-07
The filing itself
1.0%Dividend yield
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed
- computed
- computed
- computed
- computed
- Computed from the filing for 2026, filed 2026-05-29

Price is the furthest below its sector's middle: 0.31 against 0.36 on the market's range.

All from 100

lens 2 of 9

Sales

227

2017-03-31 to 2026-03-31100 at the start227

Sales: 100.00 on 2017-03-31 to 227.19 on 2026-03-31, up 127%.

Profit

711

2017-03-31 to 2026-03-31100 at the start711

Profit: 100.00 on 2017-03-31 to 711.41 on 2026-03-31, up 611%.

Shares in issue

115

2017-03-31 to 2026-03-31100 at the start115

Shares in issue: 100.00 on 2017-03-31 to 114.64 on 2026-03-31, up 15%.

Sales is at 227, Profit is at 711, Shares in issue is at 115, against 100 in 2017.

Sales is at 227, Profit is at 711, Shares in issue is at 115, against 100 in 2017.

Every figure in this lens

Except where said otherwise: 10-K for 2026, filed 2026-05-29

Sales, where the first year is 100227
Source
filed
Statement
income
Fiscal year
2026
Accession
0001628280-26-039136
Reported in
USD
The filing itself
Profit, where the first year is 100711
Source
filed
Statement
income
Fiscal year
2026
Accession
0001628280-26-039136
Reported in
USD
The filing itself
Shares in issue, where the first year is 100115
Source
filed
Statement
income
Fiscal year
2026
Accession
0001628280-26-039136
Reported in
USD
The filing itself